SpecificationsOrganism/cell line/tissue*Homo sapiens*/colon FFPE tissueSexFemaleSequencer or array typeAffymetrix Human Genome U133 Plus 2.0, Affymetrix U133_X3P ArrayData formatRaw microarray data (.CEL files) and analyzed data (.CHP files)Experimental factorsHGU133 Plus 2.0 + 3′ IVT kit, X3P Array + 3′ IVT kit, HGU133 Plus 2.0 + Nugen Ovation FFPE WTA System Kit, X3P Array + Nugen Ovation FFPE WTA System Kit and tumor vs. normal for X3P Array + Nugen Ovation FFPE WTA System KitExperimental featuresFour 8-μm-thick colon paraffin-embedded tissue sections were used for RNA extractions. Four different hybridization combinations were performed on four labeled samples using two different kits (Affymetrix 3′ IVT kit and the NuGEN Ovation FFPE WTA system) and two different arrays (Human Genome U133 Plus 2.0 and U133_X3P arrays). Three of these four samples have matched control samples. Gene expression data analysis was also performed for these three matched samples. Totally, this dataset includes 19 arrays.ConsentInformed consent was obtained from all patients.Sample source locationAnkara University, Faculty of Medicine, Department of Pathology, Ankara, Turkey

1. Direct link to deposited data {#s0005}
================================

[*http*://*www.ncbi.nlm.nih.gov*/*geo*/*query*/*acc.cgi*?*acc*=*GSE73883*](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73883){#ir0005}

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental design {#s0015}
------------------------

A comparison study was conducted assessing two different microarray chips and amplification kits for performance comparison. All steps are represented in [Fig. 1](#f0005){ref-type="fig"}.

RNA was extracted from four sporadic colorectal cancer FFPE samples using Qiagen RNeasy extraction kit with modified deparaffinization step. The yield and quality of RNA samples were evaluated using a Nanodrop Spectrophotometer and a Agilent 2100 Bioanalyzer. We assessed microarray performance by comparing four combinations of two different cDNA preparation & labeling protocols and microarray chips. Finally, gene expression data analysis was performed for three matched samples using U133 X3 + NuGEN Ovation FFPE WTA System combination.

2.2. FFPE tissue materials {#s0020}
--------------------------

FFPE tissue samples were obtained from four colon adenocarcinoma patients. Local ethical approval was obtained for using the human material (Research Ethics Committee of Medical Faculty of Ankara University, Ankara Ref: 153-4854). Four different 6--10 year old FFPE blocks were used in this study (08/40 T(TT01), 08/95 T(TT08), 09/137 T(TT24) and 10/12 T(TT31) were collected in 2007, 2005, 2009, and 2006 respectively). Three of these four samples have matched control samples (08/40 T(NT01), 08/95 T(NT08) and 10/12 T(NT31)).

2.3. Characteristics of patients {#s0025}
--------------------------------

Four tumor samples and three matched controls of these four samples were used for microarray analysis. All cases were sporadic colorectal cancers from female patients within the age of 27 to 48 years. The histotype of the tumors was conventional adenocarcinoma. The patients had stage III disease and 75% of the patients have left colon sided. All clinico-pathological parameters of the patients are given in [Table 1](#t0005){ref-type="table"}.

2.4. Preparation of FFPE tissue samples and RNA extraction {#s0030}
----------------------------------------------------------

All steps were performed under RNase-free conditions. Four of 8 μm-thick sections were cut from FFPE blocks, on a microtome with a disposable blade. Two of the sections were placed on per microscope slide. The tumor area containing \~ 90% tumor cells was used for macrodissection.

Four sections were used for RNA extraction. Total RNA was isolated using Qiagen RNeasy FFPE kit (Qiagen, Hilden, Germany) according to the manufacturers\' instructions except deparaffinization step. The deparaffinization step was optimized by comparing our laboratory deparaffinization protocol with Qiagen RNeasy FFPE kit\'s deparaffinization step. These comparisons and their results were given in detail in our manuscript accepted to be published in Pathology Research and Practice [@bb0025]. RNA samples extracted from FFPE tissues were analyzed in terms of RNA concentration and purity using NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA).

The quality of RNA samples was assessed with RNA 6000 Nano Assay on Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA). RNA degradation degree assessment was also checked with PCR which was performed by amplifying seven different amplicon sets that produced fragments ranging from 101 to 246 bp (B2M-101 bp, HPRT-113 bp, VEGFA-168 bp, MAPK14-198 bp, TCF19-201 bp, TGFB1-240 bp, NCAPG-246 bp).

2.5. In vitro transcription, amplification, labeling and hybridization for gene expression analysis {#s0035}
---------------------------------------------------------------------------------------------------

The RNA samples extracted from FFPE samples were amplified and labeled using the 3′ IVT kit (Affymetrix, Santa Clara, CA) and the Ovation FFPE WTA System (NuGEN San Carlos, CA, USA). Human Genome U133 Plus 2.0 and U133_X3P arrays were used for hybridization. Four combinations were used to determine which pairwise combination gives the best result in terms of percentage of present call.

Four combinations depicted in [Table 2](#t0010){ref-type="table"} were applied on the four tumor samples. One of these four combinations was applied on the matched normal samples of three of the four samples. In the combinations where 3′ IVT kit (Affymetrix, USA) is used manufacturer\'s protocol was followed for all steps. Secondly we assessed NugenRibo-SPIA method for amplification process. In the combinations where Ovation FFPE WTA System (NuGEN San Carlos, CA, USA) is used manufacturer\'s protocol was followed for the amplification and labeling steps except for the fragmentation performed from 3.5 μg of input cDNA instead of 4--5 μg recommended in Nugen Ovation FFPE WTA System user guide. The starting RNA amount for cDNA synthesis, the hybridized cRNA (Affymetrix) and cDNA (Nugen) amount and hybridization conditions are given in [Table 2](#t0010){ref-type="table"}. For all four combinations the arrays were washed and stained using user-prepared wash and stain reagents as specified in the Affymetrix GeneChip® Expression Wash, Stain and Scan User Guide (P/N 702731 Rev. 4, pp. 14--20). Gene Chips Fluidics Station 450 is used for the wash and stain step. The hybridized arrays were scanned by a GeneChip Scanner 3000 7G and images were generated using Affymetrix GeneChip Command Console (AGCC) program.

2.6. Statistical data analysis {#s0040}
------------------------------

Two different amplification kits and two different Affymetrix microarray platforms were combined separately for four samples and performance comparison was performed for each pairwise comparison. In addition, we had three samples that were the matched controls of four samples. These three matched normal controls were independently isolated with Qiagen RNeasy FFPE kit, amplified, fragmented and labeled using Nugen Ovation FFPE WTA System for another larger microarray gene expression study. These samples were also hybridized to U133_X3P Array. Gene expression microarray analysis was carried out for three matched tumor and control samples. Totally, our GEO entry has raw data for 19 arrays and 11 of them are for U133_X3P Array and 8 of them are for U133 Plus 2.0. The entire microarray data set has been deposited at the Gene Expression Omnibus (GEO) database with Accession Number GSE73883.

All of the raw data (CEL files) were preprocessed using AffymetrixGeneChip Command Console software (version 3.0.1). The percentage present calls were generated with Affymetrix MAS 5.0 expression algorithm. Group comparisons were performed using Student\'s t test and one-way ANOVA. All analyses were implemented using IBM SPSS Statistics version 20. A p \< 0.005 was considered as statistically significant.

Partek Genomic Suite 6.6 software (Partek Inc., St. Louis, MO, USA) was used for paired three tumor and control sample gene expression data analysis. Array data files with a .CEL extension were preprocessed for background correction and quantile normalization using Robust multiarray averaging (RMA). Paired t test was performed to identify differentially expressed genes. Fold-change values of − 2 to 2 at a false discovery rate of ≤ 5% and p-value cutoff of 0.001 were used as a filtering criteria to find statistically significantly expressed genes. We then performed unsupervised hierarchical cluster analysis for significant 504 differentially expressed genes to visualize patterns of expression in tumor and control samples. Euclidean distance and average linkage algorithm were used for clustering in the Partek Genomic Suite.

3. Discussion {#s0045}
=============

Here, we provide detailed description of methods for our microarray optimization and comparison study to help reusing of microarray data obtained from FFPE extracted RNA. We believe that our conducted workflow is useful and generally applicable to produce reliable gene expression data from FFPE extracted RNA. These results highlight that FFPE samples can be used as an alternative material to FF tissues for microarray gene expression studies. The entire results were also published in our recent accepted manuscript [@bb0025].
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![A schematic representation of entire experimental workflow.](gr1){#f0005}

###### 

Clinicopathological features of four colorectal cancer patients.

  Sample name         Tissue            Age   Gender   Histology        Tumor location      Grade       Stage
  ------------------- ----------------- ----- -------- ---------------- ------------------- ----------- ------------
  TT01 tumor_08/40    Colorectal FFPE   26    Female   Adenocarcinoma   Right sided colon   Grade III   Stage IIIB
  TT08 tumor_08/95    Colorectal FFPE   46    Female   Adenocarcinoma   Left sided colon    Grade II    Stage IIIB
  TT24 tumor_09/137   Colorectal FFPE   32    Female   Adenocarcinoma   Left sided colon    Grade I     Stage IIIB
  TT31 tumor_10/12    Colorectal FFPE   48    Female   Adenocarcinoma   Left sided colon    Grade II    Stage IIIB

###### 

Combinations and their corresponding experiment conditions of four colorectal cancers.

  CEL data files     HGU133 plus 2.0   X3P array   Affymetrix 3\' IVT kit   Nugen ovation FFPE WTA system kit   RNA input   aRNA/cDNA input   Hybridization time/°C
  ------------------ ----------------- ----------- ------------------------ ----------------------------------- ----------- ----------------- -----------------------
  TT01_Nugen_Plus2                                                                                              100 ng      3.5 μg            19 h/45 °C
  TT08_Nugen_Plus2                                                                                                                            
  TT24_Nugen_Plus2                                                                                                                            
  TT31_Nugen_Plus2                                                                                                                            
  TT01_IVT_X3P                                                                                                  500 ng      15 μg             16 h/45 °C
  TT08_IVT_X3P                                                                                                                                
  TT24_IVT_X3P                                                                                                                                
  TT31_IVT_X3P                                                                                                                                
  TT01_Nugen_X3P                                                                                                100 ng      3.5 μg            19 h/45 °C
  TT08_Nugen_X3P                                                                                                                              
  TT24_Nugen_X3P                                                                                                                              
  TT31_Nugen_X3P                                                                                                                              
  TT01_IVT_Plus2                                                                                                500 ng      15 μg             16 h/45 °C
  TT08_IVT_Plus2                                                                                                                              
  TT24_IVT_Plus2                                                                                                                              
  TT31_IVT_Plus2                                                                                                                              
  NT01_Nugen_X3P                                                                                                100 ng      3.5 μg            19 h/45 °C
  NT08_Nugen_X3P                                                                                                                              
  NT31_Nugen_X3P                                                                                                                              
